福元医药
(601089)
| 流通市值：32.94亿 | | | 总市值：76.99亿 |
| 流通股本：2.05亿 | | | 总股本：4.80亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,004,940,414.02 | 794,067,803.65 | 974,094,073.63 | 1,240,999,787.72 |
| 应收票据及应收账款 | 353,475,377.93 | 354,656,351.21 | 347,584,668.1 | 344,184,813.03 |
| 应收账款 | 353,475,377.93 | 354,656,351.21 | 347,584,668.1 | 344,184,813.03 |
| 应收款项融资 | 84,887,204.79 | 97,425,194.26 | 86,844,068 | 72,210,098.42 |
| 预付款项 | 35,848,453.37 | 24,504,710.43 | 32,700,471.46 | 32,768,358.4 |
| 其他应收款合计 | 3,095,716.46 | 1,201,965.77 | 1,553,590.05 | 1,754,566.52 |
| 存货 | 329,944,868.46 | 347,555,462.41 | 344,014,911.9 | 336,048,032.45 |
| 其他流动资产 | 4,057,927.94 | 2,751,027.04 | 3,760,973.23 | 2,694,172.01 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,056,249,962.97 | 3,201,162,514.77 | 3,118,552,756.37 | 3,090,659,828.55 |
| 非流动资产: | | | | |
| 固定资产 | 1,284,606,240.34 | 673,167,008.85 | 670,454,627.99 | 677,698,851.17 |
| 在建工程 | 315,701,323.31 | 719,151,066.27 | 507,678,552.93 | 361,220,548.73 |
| 使用权资产 | 30,792,229.66 | 33,477,211.76 | 36,552,922.69 | 40,469,328.32 |
| 无形资产 | 141,450,842.73 | 139,209,080.8 | 141,367,473.81 | 144,460,016.35 |
| 长期待摊费用 | 20,011,761.55 | 21,816,310.33 | 20,642,104.76 | 22,265,327.22 |
| 递延所得税资产 | 2,730,861.7 | 3,308,072.57 | 2,466,118.04 | 2,432,497.39 |
| 其他非流动资产 | 17,576,621.09 | 25,341,119.71 | 38,939,446.49 | 97,631,429.65 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,812,869,880.38 | 1,615,469,870.29 | 1,418,101,246.71 | 1,346,177,998.83 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,869,119,843.35 | 4,816,632,385.06 | 4,536,654,003.08 | 4,436,837,827.38 |
| 流动负债: | | | | |
| 短期借款 | 10,011,166.67 | 40,033,533.34 | 49,938,269.45 | 49,939,102.78 |
| 应付票据及应付账款 | 266,994,507.71 | 286,760,509.03 | 140,214,823.65 | 127,443,210.13 |
| 应付账款 | 266,994,507.71 | 286,760,509.03 | 140,214,823.65 | 127,443,210.13 |
| 预收款项 | 60,099.99 | 82,800 | 492,973.1 | 517,398.09 |
| 合同负债 | 38,829,450.66 | 36,591,930.56 | 53,741,648.2 | 74,082,798.09 |
| 应付职工薪酬 | 82,273,629.15 | 143,641,602.55 | 125,542,446.75 | 102,926,745.2 |
| 应交税费 | 38,444,662.52 | 46,120,302.17 | 36,411,812.78 | 29,757,609.61 |
| 其他应付款合计 | 636,822,516.28 | 589,762,121.35 | 567,807,808.03 | 553,043,330.43 |
| 一年内到期的非流动负债 | 14,475,363.15 | 14,334,663.9 | 15,287,658.04 | 21,600,399.23 |
| 其他流动负债 | 28,913,268.53 | 32,612,085.46 | 28,695,277.88 | 27,868,741.29 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,116,824,664.66 | 1,189,939,548.36 | 1,018,132,717.88 | 987,179,334.85 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 9,898,088.82 |
| 租赁负债 | 16,131,474.14 | 20,793,200.3 | 21,713,117.63 | 26,026,008.74 |
| 递延收益 | 34,111,287.99 | 34,490,321.55 | 9,537,471.78 | 9,863,155.44 |
| 递延所得税负债 | 15,607,122.41 | 15,327,927.35 | 19,165,794.14 | 18,753,193.91 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 65,849,884.54 | 70,611,449.2 | 50,416,383.55 | 64,540,446.91 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,182,674,549.2 | 1,260,550,997.56 | 1,068,549,101.43 | 1,051,719,781.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 480,000,000 | 480,000,000 | 480,000,000 | 480,000,000 |
| 资本公积 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 |
| 减:库存股 | 176,186,608.79 | 176,186,608.79 | 176,186,608.79 | 148,626,645.16 |
| 专项储备 | 10,536,073.51 | 10,977,571.6 | 10,997,433.02 | 12,093,136.51 |
| 盈余公积 | 192,060,121.76 | 192,060,121.76 | 154,181,999.35 | 154,181,999.35 |
| 未分配利润 | 1,505,945,270.24 | 1,375,312,235.02 | 1,325,465,344.59 | 1,215,136,731.73 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,674,747,575.23 | 3,544,556,038.1 | 3,456,850,886.68 | 3,375,177,940.94 |
| 少数股东权益 | 11,697,718.92 | 11,525,349.4 | 11,254,014.97 | 9,940,104.68 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,686,445,294.15 | 3,556,081,387.5 | 3,468,104,901.65 | 3,385,118,045.62 |
| 负债和股东权益合计 | 4,869,119,843.35 | 4,816,632,385.06 | 4,536,654,003.08 | 4,436,837,827.38 |
| 公告日期 | 2025-04-30 | 2025-04-01 | 2024-10-25 | 2024-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |